サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1782866

母親のメンタルヘルスの世界市場

Maternal Mental Health

出版日
ページ情報
英文 283 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
母親のメンタルヘルスの世界市場
出版日: 2025年08月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 283 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

母親のメンタルヘルスの世界市場は2030年までに398億米ドルに達する見込み

2024年に99億米ドルと推定される母親のメンタルヘルスの世界市場は、分析期間2024-2030年にCAGR 26.0％で成長し、2030年には398億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである産後うつ病の適応症は、CAGR 23.6％を記録し、分析期間終了までに94億米ドルに達すると予測されます。ディスチミア（Dysthymia）疾患適応症セグメントの成長率は、分析期間中CAGR 29.2%と推定されます。

米国市場は27億米ドルと推定、中国はCAGR 33.8％で成長予測

米国の母親のメンタルヘルス市場は2024年に27億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 33.8%で推移し、2030年には96億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ21.2%と23.2%と予測されています。欧州では、ドイツがCAGR 21.8%で成長すると予測されています。

世界の母親のメンタルヘルス市場- 主要動向と促進要因まとめ

母親のメンタルヘルスがようやく注目されるようになった理由とは？

母親のメンタルヘルスは、世界の公衆衛生の重要な要素として急速に認知されつつあり、かつては目立たなかった位置づけから、ヘルスケアの話題の最前線に躍り出た。産後うつ病、周産期不安、妊娠中および妊娠後の気分障害に対する認識が高まり、アドボカシー活動や政策への関心が高まっています。何十年もの間、母親のメンタルヘルスの問題は、社会的スティグマ、限られたスクリーニングプロトコル、統合ケアの枠組みの欠如のために、過小診断され、過小治療されてきました。今日、科学的な証拠や世論が高まり、母親のメンタルヘルスが母親だけでなく、乳幼児の発育、パートナーとの関係、家族の幸福にも大きな影響を与えることが明らかになりつつあります。経済的不安や社会的孤立から、医学的合併症や睡眠不足に至るまで、現代の母親業のストレス要因は、新米母親の精神的負担を強めています。COVID-19の大流行は、こうした課題をさらに悪化させ、閉鎖、ヘルスケアへのアクセスの途絶、支援制度の制限によって、世界的に妊産婦の苦痛が著しく増大した。これに対し、政府、NGO、保健機関は、検診プログラム、教育キャンペーン、早期介入戦略に投資しています。文化的な語り口も変化し、女性が自分の苦悩を率直に語り、タイムリーなケアを求めるようになり、母親のメンタルヘルスはより広範な女性の健康課題の優先事項へと変化しています。

デジタルヘルスにおけるイノベーションは、妊産婦のメンタルヘルスの提供にどのような変化をもたらしているのか？

テクノロジーは、妊産婦のメンタルヘルス・ヘルスケアの提供方法、アクセス方法、規模の拡大方法を再構築する上で、重要な役割を果たしています。モバイルアプリ、遠隔精神医療、バーチャルサポートグループなどのデジタルヘルスプラットフォームは、従来のメンタルヘルスサービスを利用できない新米妊婦のケアギャップを埋めつつあります。AIを搭載したメンタルヘルス・ツールは、行動の変化をモニターし、危険因子をスクリーニングし、産後や周産期の段階に合わせた認知行動療法（CBT）モジュールを提供するために開発されています。モバイル・ファーストのアプローチは、インフラやヘルスケア人材の不足により対面サービスへのアクセスが制限される、農村部や十分なサービスを受けられない地域において特に効果的です。ウェアラブル・テクノロジーやヘルス・トラッカーも、睡眠パターン、ストレス・レベル、ホルモンの変動（母親のメンタルヘルスの重要な指標）をモニターするのに役立つ、支援ツールとして台頭してきています。さらに、統合された妊産婦の健康プラットフォームは、現在、産科的な追跡と同時にメンタルヘルスのリソースを提供し、よりホリスティックなケア体験を生み出しています。セラピストやメンタルヘルスの専門家とのバーチャルな相談は、スティグマを減らし、新生児のケアと回復を両立させる女性のための慎重で柔軟なサポートを可能にしています。こうした技術革新は、早期診断と早期介入を強化するだけでなく、メンタルヘルスケアを民主化し、より包括的で母性特有の感情的状況に対応できるものにしています。

雇用主、保険者、医療システムの役割の進化は市場拡大を促進するか？

母親のメンタルヘルスのエコシステムは、従来のヘルスケア・プロバイダーを超えた利害関係者のネットワークの拡大によって再構築されつつあります。雇用主は妊産婦のメンタルウェルネスを労働力の生産性と定着に不可欠な要素として捉え始めており、従業員支援プログラム（EAP）に産後のメンタルヘルスリソースを含めることを促しています。企業のウェルネス・プラットフォームは現在、新米育児カウンセリング、マインドフルネス・ツール、出産後の職場復帰の感情的な複雑さを認める柔軟な休暇規定を提供しています。保険会社もこれに注目しており、一部の医療保険制度では、産後セラピー、出産前診察の際のメンタルヘルス・スクリーニング、アプリを利用したメンタル・ウェルネスの購読料が払い戻されるようになっています。一方、医療システムは、メンタルヘルス評価を標準的な産前産後ケア経路に統合しており、多くの場合、健診時にエジンバラ産後うつ尺度（EPDS）のような標準化されたツールを使用しています。産科医、助産師、セラピスト、小児科医で構成される集学的ケアチームは、メンタルヘルスの懸念を早期に発見し、対処するための連携ケアモデルを構築しています。公衆衛生の取り組みとドナーからの資金援助により、特に資源の乏しい環境において、母親のメンタルヘルスのスクリーニングについて地域保健ワーカーを訓練する試験的プログラムが実施されています。政策レベルでは、母親のメンタルヘルスに関する法律がいくつかの国で導入され、普遍的なスクリーニングを確保し、ケアへのアクセスを改善しています。制度的な支援が高まるにつれ、デジタル治療薬、支援ネットワーク、文化的に適応したメンタルヘルスサービスなど、拡張性のあるソリューションへの需要が地域全体で加速しています。

母親のメンタルヘルス市場の拡大を促す中核要因は何か？

母親のメンタルヘルス市場の成長は、進化するヘルスケア提供モデル、社会規範の変化、テクノロジー主導のイノベーションに根ざしたいくつかの要因によって牽引されています。未治療の母親のメンタルヘルス状態が臨床的・社会的に及ぼす影響に対する意識の高まりは、特に母子保健プログラムにおいて、早期スクリーニングと介入プロトコルへの投資の増加につながりました。デジタル・プラットフォームの普及により、特にテクノロジーに精通し、柔軟でスティグマのない支援オプションを求める若い母親の間で、ケアへのアクセスが拡大しています。母体形成の遅れやハイリスク妊娠の割合の増加といった人口動態の変化は、周産期における情緒的脆弱性を増大させる一因となっており、予防的メンタルヘルスサービスに対する需要を煽っています。産科や小児科の環境における行動衛生の統合が進むことで、妊娠中から産後まで継続的にメンタルヘルスをモニタリングするための構造的な道筋ができつつあります。保険制度改革や雇用主が支援する医療イニシアティブは、公的部門と民間部門の両方において、母親のメンタルヘルスサービスの償還と利用を促進しています。さらに、文化的に配慮された多言語コンテンツが利用できるようになったことで、多様な人々へのより良い働きかけが可能になりつつあります。中低所得国では、ドナー主導のプログラムや世界・ヘルス・パートナーシップが草の根の介入やメンタルヘルス・トレーニングの規模を拡大し、先進地域以外にも市場の可能性を広げています。母親のメンタルヘルスの物語が消極的な治療から積極的なウェルネスへと進化するにつれ、世界中のサービス、テクノロジー、サポート・エコシステムに対する持続的で多様な需要が生まれています。

セグメント

疾患別適応症（産後うつ病適応症、ディスチミア適応症、妊娠中・産後全般性不安障害適応症、妊娠中・産後強迫性障害適応症、出産関連PTSD適応症、その他の疾患別適応症）、治療法（抗うつ薬治療、対人関係療法、認知行動療法、その他の治療法）

調査対象企業の例

  • Ahma & Co Postpartum Retreat
  • Anne Arundel Medical Center Maternal Mental Health
  • BetterHelp
  • COOJ Mental Health Foundation
  • Inova Perinatal Mental Health
  • Mammha
  • Maternal Mental Health Alliance
  • Maternal Mental Health Leadership Alliance
  • MPower Minds
  • MS Chellamuthu Trust & Research Foundation
  • Parivarthan Counselling, Training and Research Centre
  • Policy Center for Maternal Mental Health
  • Postpartum Support International
  • Seleni Institute
  • Tele-MANAS
  • The Live Love Laugh Foundation
  • The Motherhood Group

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32003

Global Maternal Mental Health Market to Reach US$39.8 Billion by 2030

The global market for Maternal Mental Health estimated at US$9.9 Billion in the year 2024, is expected to reach US$39.8 Billion by 2030, growing at a CAGR of 26.0% over the analysis period 2024-2030. Postpartum Depression Disease Indication, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Dysthymia Disease Indication segment is estimated at 29.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 33.8% CAGR

The Maternal Mental Health market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.6 Billion by the year 2030 trailing a CAGR of 33.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.2% and 23.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.8% CAGR.

Global Maternal Mental Health Market - Key Trends & Drivers Summarized

Why Is Maternal Mental Health Finally Receiving the Attention It Deserves?

Maternal mental health is rapidly gaining recognition as a vital component of global public health, moving beyond its once-muted position to the forefront of healthcare conversations. Increased awareness around postpartum depression, perinatal anxiety, and mood disorders during and after pregnancy has led to growing advocacy and policy focus. For decades, maternal mental health issues were underdiagnosed and undertreated due to social stigma, limited screening protocols, and a lack of integrated care frameworks. Today, growing scientific evidence and public discourse are highlighting the profound impact maternal mental health can have not only on mothers but also on infant development, partner dynamics, and family wellbeing. The stressors of modern motherhood-ranging from economic insecurity and social isolation to medical complications and sleep deprivation-are intensifying the mental health burden among new mothers. The COVID-19 pandemic further exacerbated these challenges, with lockdowns, disrupted healthcare access, and limited support systems significantly increasing maternal distress globally. In response, governments, NGOs, and health institutions are investing in maternal mental health screening programs, educational campaigns, and early intervention strategies. Cultural narratives are also shifting, empowering women to speak openly about their struggles and seek timely care, transforming maternal mental health into a priority within broader women’s health agendas.

How Are Innovations in Digital Health Transforming Maternal Mental Healthcare Delivery?

Technology is playing an instrumental role in reshaping how maternal mental healthcare is delivered, accessed, and scaled. Digital health platforms, including mobile apps, telepsychiatry, and virtual support groups, are bridging care gaps for new and expecting mothers who may lack access to traditional mental health services. AI-powered mental health tools are being developed to monitor behavioral changes, screen for risk factors, and deliver cognitive behavioral therapy (CBT) modules tailored for postpartum and perinatal stages. Mobile-first approaches are particularly effective in rural and underserved regions, where infrastructure and healthcare personnel shortages limit access to in-person services. Wearable technology and health trackers are also emerging as supportive tools, helping monitor sleep patterns, stress levels, and hormonal fluctuations-key indicators of maternal mental health. Moreover, integrated maternal health platforms now offer mental health resources alongside obstetric tracking, creating a more holistic care experience. Virtual consultations with therapists and mental health professionals are reducing stigma and enabling discreet, flexible support for women juggling newborn care and recovery. These innovations are not only enhancing early diagnosis and intervention but also democratizing mental health care, making it more inclusive and responsive to the unique emotional landscape of motherhood.

Is the Evolving Role of Employers, Insurers, and Health Systems Driving Market Expansion?

The maternal mental health ecosystem is being reshaped by an expanding network of stakeholders beyond traditional healthcare providers. Employers are beginning to view maternal mental wellness as a critical component of workforce productivity and retention, prompting the inclusion of postpartum mental health resources in employee assistance programs (EAPs). Corporate wellness platforms now offer new-parent counseling, mindfulness tools, and flexible leave policies that acknowledge the emotional complexities of returning to work after childbirth. Insurers are also taking note-some health plans now reimburse for postpartum therapy, mental health screenings during prenatal visits, and app-based mental wellness subscriptions. Meanwhile, health systems are integrating mental health assessments into standard prenatal and postnatal care pathways, often using standardized tools like the Edinburgh Postnatal Depression Scale (EPDS) during checkups. Multidisciplinary care teams-comprising obstetricians, midwives, therapists, and pediatricians-are creating coordinated care models to identify and address mental health concerns early. Public health initiatives and donor funding are supporting pilot programs that train community health workers in maternal mental health screening, especially in low-resource settings. At the policy level, maternal mental health legislation is being introduced in several countries to ensure universal screening and improve care access. As systemic support increases, demand for scalable solutions-including digital therapeutics, support networks, and culturally adapted mental health services-is accelerating across geographies.

What Are the Core Drivers Powering the Maternal Mental Health Market’s Expansion?

The growth in the maternal mental health market is driven by several factors rooted in evolving healthcare delivery models, shifting societal norms, and technology-driven innovation. Rising awareness of the clinical and social implications of untreated maternal mental health conditions has led to increased investment in early screening and intervention protocols, particularly within maternal and child health programs. The widespread use of digital platforms is expanding access to care, especially among younger, tech-savvy mothers seeking flexible and stigma-free support options. Demographic shifts, such as delayed motherhood and higher rates of high-risk pregnancies, are contributing to increased emotional vulnerability during the perinatal period, thus fueling demand for preventive mental health services. The growing integration of behavioral health into obstetric and pediatric settings is creating structural pathways for continuous mental health monitoring from pregnancy through postpartum. Insurance reforms and employer-backed health initiatives are driving reimbursement and utilization of maternal mental health services across both public and private sectors. Additionally, the increasing availability of culturally sensitive and multilingual content is enabling better outreach among diverse populations. In low- and middle-income countries, donor-led programs and global health partnerships are scaling grassroots interventions and mental health training, expanding market potential beyond developed regions. As the maternal mental health narrative evolves from reactive treatment to proactive wellness, it is creating a sustained and diversified demand for services, technologies, and support ecosystems worldwide.

SCOPE OF STUDY:

The report analyzes the Maternal Mental Health market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication, Other Disease Indications); Therapy (Antidepressants Therapy, Interpersonal Psychotherapy, Cognitive Behavioral Therapy, Other Therapies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Ahma & Co Postpartum Retreat
  • Anne Arundel Medical Center Maternal Mental Health
  • BetterHelp
  • COOJ Mental Health Foundation
  • Inova Perinatal Mental Health
  • Mammha
  • Maternal Mental Health Alliance
  • Maternal Mental Health Leadership Alliance
  • MPower Minds
  • MS Chellamuthu Trust & Research Foundation
  • Parivarthan Counselling, Training and Research Centre
  • Policy Center for Maternal Mental Health
  • Postpartum Support International
  • Seleni Institute
  • Tele-MANAS
  • The Live Love Laugh Foundation
  • The Motherhood Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Maternal Mental Health - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness Around Postpartum Depression Throws the Spotlight on Early Detection and Support Services
    • Global Push for Holistic Maternal Care Strengthens Business Case for Integrated Mental Health Screening
    • Increased Burden of Stress and Anxiety During Pregnancy Expands Addressable Market Opportunity for Preventive Interventions
    • Shift Toward Virtual Care Models Spurs Growth in Teletherapy and Digital Counseling for Expecting and New Mothers
    • Here's the Story: Social Media and Influencer Advocacy Normalize Conversations Around Maternal Mental Well-Being
    • Workforce Reentry Pressures and Parental Guilt Drive Demand for Emotional Support and Resilience Programs
    • Growing Integration of Behavioral Health in OB/GYN Settings Drives Adoption of Routine Mental Health Checkpoints
    • Here's How Mobile Health Apps and Digital Journals Empower Self-Monitoring and Early Symptom Reporting
    • Rising Incidence of Maternal Suicide and Untreated Disorders Propels Policy-Level Intervention and Care Funding
    • Cultural Shifts and Urban Isolation Accelerate Demand for Community-Based Maternal Support Networks
    • Adoption of AI-Powered Chatbots and Virtual Companions Creates Scalable, Non-Stigmatizing Mental Health Avenues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Maternal Mental Health Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Postpartum Depression Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Dysthymia Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Birth-Related PTSD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Antidepressants Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Interpersonal Psychotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cognitive Behavioral Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • CHINA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • INDIA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030

IV. COMPETITION